Quality of life worsened the most severely in patients immediately after intensity-modulated radiation therapy for prostate cancer

Quality of life worsened the most severely in patients immediately after intensity-modulated radiation therapy for prostate cancer

Yasushi Nakai,1 Nobumichi Tanaka,1 Satoshi Anai,1 Makito Miyake,1 Isao Asakawa,2 Yosuke Morizawa,1 Shunta Hori,1 Kazumasa Torimoto,1 Tomomi Fujii,3 Masatoshi Hasegawa,2 Kiyohide Fujimoto1 1Department of Urology, Nara Medical University, Nara, Japan; 2Department of Radiation Oncology, Nara Medical Un...

Full description

Bibliographic Details
Main Authors:	Nakai Y, Tanaka N, Anai S, Miyake M, Asakawa I, Morizawa Y, Hori S, Torimoto K, Fujii T, Hasegawa M, Fujimoto K
Format:	Article
Language:	English
Published:	Dove Medical Press 2018-10-01
Series:	Research and Reports in Urology
Subjects:	chronological changes intensity-modulated radiation therapy prostate cancer quality of life radiation therapy
Online Access:	https://www.dovepress.com/quality-of-life-worsened-the-most-severely-in-patients-immediately-aft-peer-reviewed-article-RRU

Similar Items

Comparison of cancer detection rates by transrectal prostate biopsy for prostate cancer using two different nomograms based on patient’s age and prostate volume
by: Hori S, et al.
Published: (2019-03-01)

Trends in risk classification and primary therapy of Japanese patients with prostate cancer in Nara urological research and treatment group (NURTG) – comparison between 2004–2006, 2007–2009, and 2010–2012
by: Nobumichi Tanaka, et al.
Published: (2017-09-01)

Inhibition of COX-2 expression by topical diclofenac enhanced radiation sensitivity via enhancement of TRAIL in human prostate adenocarcinoma xenograft model
by: Inoue Takeshi, et al.
Published: (2013-01-01)

Adaptive magnetic resonance image guided radiation for intact localized prostate cancer how to optimally test a rapidly emerging technology
by: William A. Hall, et al.
Published: (2022-09-01)

Prostate cancer : image-guided radiation therapy /
by: Valicenti, Richard K., et al.
Published: (2008)

Potential effectiveness of local radiotherapy for extending survival and reducing symptomatic local events in patients with de novo metastatic prostate cancer
by: Naoki Terada, et al.
Published: (2020-11-01)

The Current Trend of Radiation Therapy for Patients with Localized Prostate Cancer
by: Kazuyuki Numakura, et al.
Published: (2023-09-01)

CT-based online adaptive radiotherapy improves target coverage and organ at risk (OAR) avoidance in stereotactic body radiation therapy (SBRT) for prostate cancer
by: Michael Waters, et al.
Published: (2024-01-01)

Consensus Statement on Proton Therapy for Prostate Cancer
by: Curtis M. Bryant, MD, MPH, et al.
Published: (2021-04-01)

Prostate Cancer – Local Treatment after Radiorecurrence: Surgery - Back to the future?
by: Leonardo O. Reis, et al.

Long-term outcomes of prostate intensity-modulated radiation therapy incorporating a simultaneous intra-prostatic MRI-directed boost
by: Brady S. Laughlin, et al.
Published: (2022-08-01)

Case-Matched Outcomes of Proton Beam and Intensity-Modulated Radiation Therapy for Localized Prostate Cancer
by: Alicia Bao, BS, et al.
Published: (2023-05-01)

Oncological outcome, complications, lower urinary tract symptoms, and health-related quality of life after low-dose-rate salvage brachytherapy for recurrent prostate cancer following primary radiotherapy: a report of 8 cases
by: Makito Miyake, et al.
Published: (2017-07-01)

Twelve-year outcomes of prostate cancer after radical prostatectomy for T3 and/or positive margins managed with surveillance or salvage radiation therapy, based on risk groups
by: Barry W. Goy, et al.
Published: (2021-12-01)

Visualising the urethra for prostate radiotherapy planning
by: Matthew Richardson, et al.
Published: (2021-09-01)

Factors determining the efficacy of radiotherapy for prostate cancer
by: О. Ю. Столярова, et al.
Published: (2021-03-01)

Quality of life of men treated with brachytherapies for prostate cancer
by: Owen Steven V, et al.
Published: (2004-06-01)

THE WAY FOR OPTIMIZATION OF DISTANT RADIATION THERAPY IN PROSTATE CANCER
by: A. S. Balkanov
Published: (2016-02-01)

Targeted Radiation and Immune Therapies—Advances and Opportunities for the Treatment of Prostate Cancer
by: Anusha Muralidhar, et al.
Published: (2023-01-01)

Antagonizing Glutamine Bioavailability Promotes Radiation Sensitivity in Prostate Cancer
by: Manish Thiruvalluvan, et al.
Published: (2022-05-01)

Assessment of lower urinary symptom flare with overactive bladder symptom score and International Prostate Symptom Score in patients treated with iodine-125 implant brachytherapy: long-term follow-up experience at a single institute
by: Makito Miyake, et al.
Published: (2017-08-01)

Triple combination therapy for clinically nonmetastatic super‐high‐risk prostate cancer
by: Koji Yoshimura, et al.
Published: (2022-07-01)

Reducing rectal injury in men receiving prostate cancer radiation therapy: current perspectives
by: Serrano NA, et al.
Published: (2017-07-01)

Adjuvant or Salvage Radiation Therapy for Prostate Cancer after Prostatectomy: Current Status, Controversies and Perspectives
by: Mario Terlizzi, et al.
Published: (2022-03-01)

Eosinophilic, polymorphic, and pruritic eruption associated with radiation therapy in two patients diagnosed with prostate cancer
by: Maria Alexandra Barbu, et al.
Published: (2023-05-01)

Effect of Prolonged Duration of Transrectal Ultrasound-Guided Biopsy of the Prostate and Pre-Procedure Anxiety on Pain in Patients without Anesthesia
by: Nakai Y, et al.
Published: (2021-03-01)

Analysis of quality of life after randomized controlled trial of alpha-1 adrenoceptor antagonist alone and in combination with cyclooxygenase-2 inhibitor in patients who underwent low-dose-rate brachytherapy for prostate cancer
by: Yasushi Nakai, et al.
Published: (2019-09-01)

Comparison of doublet and triplet therapies for metastatic hormone-sensitive prostate cancer: A systematic review and network meta-analysis
by: Lei Wang, et al.
Published: (2023-03-01)

Association of baseline self-reported fatigue with overall survival after stereotactic body radiation therapy for localized prostate cancer
by: Rishabh K. Simhal, et al.
Published: (2022-12-01)

Comparative effectiveness of surgery versus external beam radiation with/without brachytherapy in high‐risk localized prostate cancer
by: Ming Yin, et al.
Published: (2020-01-01)

Simulation of an HDR “Boost” with Stereotactic Proton versus Photon Therapy in Prostate Cancer: A Dosimetric Feasibility Study
by: Jill S. Remick, MD, et al.
Published: (2020-11-01)

Prostate-specific antigen kinetics in hypofractionated radiation therapy alone for intermediate- and high-risk localized prostate cancer
by: Tae Hoon Lee, et al.
Published: (2023-09-01)

Androgen Flare after LHRH Initiation Is the Side Effect That Makes Most of the Beneficial Effect When It Coincides with Radiation Therapy for Prostate Cancer
by: Nicola J. Nasser
Published: (2022-04-01)

Rectal Radiation Dose and Clinical Outcomes in Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy With and Without Hydrogel
by: Palak Kundu, et al.
Published: (2022-03-01)

U-Net Architectures for Prostate Cancer Radiation Therapy
by: Bruno Mendes, et al.
Published: (2023-01-01)

Intrafraction Prostate Motion Management for Ultra-Hypofractionated Radiotherapy of Prostate Cancer
by: Christoph Oehler, et al.
Published: (2022-08-01)

Irradiation of localized prostate cancer in the elderly: A systematic literature review
by: Delphine Marotte, et al.
Published: (2022-07-01)

Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results
by: Kristiina Vuolukka, et al.
Published: (2020-07-01)

Transperineal template-guided saturation biopsy aimed at sampling one core for each milliliter of prostate volume: 103 cases requiring repeat prostate biopsy
by: Yasushi Nakai, et al.
Published: (2017-04-01)

Editorial: The Evolving Landscape of Stereotactic Body Radiation Therapy for the Management of Prostate Cancer
by: Seth R. Blacksburg, et al.
Published: (2020-12-01)